LFA
AMED

Legacy Financial Advisors’s Amedisys AMED Stock Holding History

Legacy Financial Advisors’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-75
Closed -$9K – 159
2019
Q1 		$9K Buy
75
+52
+226% +$6.53K ﹤0.01% 625
2018
Q4 		$3K Buy
23
+2
+10% +$236 ﹤0.01% 793
2018
Q3 		$2K Buy
+21
New +$2.32K ﹤0.01% 792

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Legacy Financial Advisors's AMED Position: Q2 2019 in Review

Legacy Financial Advisors sold out of Amedisys (AMED) in Q2 2019, closing a stake of 75 shares — an estimated $9K sold.

Legacy Financial Advisors first reported a position in AMED in Q3 2018 and held it in 3 quarters. The position peaked at $9K in Q1 2019. 285 funds tracked by Wall St. Rank hold AMED as of Q2 2019.

  • Legacy Financial Advisors reported no remaining Amedisys position as of Q2 2019 after selling out during the quarter.
  • Legacy Financial Advisors sold 75 Amedisys shares in Q2 2019, an estimated $9K.
  • Legacy Financial Advisors first reported a position in Amedisys in Q3 2018 and held it in 3 quarters.
  • Legacy Financial Advisors's Amedisys position peaked at $9K in Q1 2019.
  • 285 funds tracked by Wall St. Rank held Amedisys as of Q2 2019.

Based on Legacy Financial Advisors's 13F filing for Q2 2019, filed 7 Aug 2019.